GLIMPIFERN-2 IMAGE
GLIMPIFERN PM1 Forte must be taken as directed by the doctor and in doses and duration as prescribed. It must be taken with meals, with the first meal of the day.
The use of GLIMPIFERN M1 Tablet is associated with common side effects like hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache.
This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise.
GLIMPIFERN-PM2 is a medication used for the management of type 2 diabetes mellitus. It helps to control blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver.
GLIMPIFERN-1 is a medication used for the treatment of type 2 diabetes mellitus. It helps to lower blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver.
GLIMPIFERN-1 typically contains Glimepiride, which is an oral antidiabetic medication belonging to the sulfonylurea class. Glimepiride stimulates insulin release from the pancreas, helping to control blood sugar levels.
GLIMPIFERN-2 is a medication used for the management of type 2 diabetes mellitus. It helps to control blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver.
GLIMPIFERN-2 typically contains two active ingredients: Glimepiride and Metformin. Glimepiride is a sulfonylurea that stimulates insulin release from the pancreas, while Metformin is a biguanide that reduces glucose production in the liver and enhances insulin sensitivity.
TENELGLIFERN-20 is a medication used for the treatment of type 2 diabetes mellitus. It helps to lower blood sugar levels by increasing insulin sensitivity and reducing glucose production in the liver.
TENELGLIFERN-20 typically contains Teneligliptin (20 mg), which is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Teneligliptin works by inhibiting the enzyme DPP-4, which increases the levels of incretin hormones. These hormones help to stimulate insulin release and suppress glucagon secretion, leading to improved blood sugar control.
VOGLIBOFERN-GM2 is a medication used for the management of type 2 diabetes mellitus. It helps to control blood sugar levels by enhancing insulin sensitivity and reducing glucose production in the liver.
VOGLIBOFERN-GM2 typically contains Voglibose and Metformin. Voglibose is an alpha-glucosidase inhibitor that delays the digestion and absorption of carbohydrates in the intestine, thereby lowering postprandial blood sugar levels. Metformin is a biguanide that reduces glucose production in the liver and enhances insulin sensitivity in tissues.
Tablet is an enzyme used to reduce pain and swelling associated with conditions like back pain, arthritis, sinusitis, etc.
FERNFLOZIN-D 10 Tablet is a combination of two medicines: Diclofenac and Serratiopeptidase.
FERNFLOZIN-DM 500 is a medication used for the treatment of type 2 diabetes mellitus. It belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by helping the kidneys remove glucose from the bloodstream and excrete it through urine.
FERNFLOZIN-DM 500 typically contains Dapagliflozin (500 mg) and Metformin (extended-release formulation). Dapagliflozin is an SGLT2 inhibitor that reduces the reabsorption of glucose by the kidneys, while Metformin helps to lower blood sugar levels by reducing glucose production in the liver and improving insulin sensitivity.
FERNGLIPTIN-VM 500 is a medication used for the management of type 2 diabetes mellitus. It helps to lower blood sugar levels by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which increases the levels of incretin hormones. These hormones help to stimulate insulin release and reduce glucagon secretion.
FERNGLIPTIN-VM 500 typically contains Vildagliptin (50 mg) and Metformin (extended-release formulation, 500 mg). Vildagliptin is a DPP-4 inhibitor that helps to enhance insulin secretion in response to meals, while Metformin works by decreasing glucose production in the liver and improving insulin sensitivity in tissues.
FERNGLIN-M2 is a medication used for the treatment of type 2 diabetes mellitus. It helps to control blood sugar levels by combining the effects of two different classes of antidiabetic drugs.
FERNGLIN-M2 typically contains Linagliptin (5 mg) and Metformin (500 mg). Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps to increase insulin secretion and decrease glucagon levels after meals. Metformin is a biguanide that reduces glucose production in the liver and improves insulin sensitivity in tissues.
